Tag: #bmi

GLP-1 Medications and Long-Term Health Outcomes: What Real-World Data Reveals About Stopping Treatment

Real-world data shows that patients who stay on GLP-1 medications are more likely to maintain meaningful weight loss and avoid serious health complications — while those who stop treatment face greater risk.

WeightControl.com Interview with:
John Wilding DM FRCP
Professor of Medicine & Honorary Consultant Physician
Department of Cardiovascular and Metabolic Medicine
Institute of Life Course and Medical Sciences
Clinical Sciences Centre
Aintree University Hospital
Liverpool, United Kingdom

A large real-world analysis of electronic health records and health claims data in the United States examines what happens to patients prescribed GLP-1 based treatments — and what the consequences are when they stop.

Continue reading “GLP-1 Medications and Long-Term Health Outcomes: What Real-World Data Reveals About Stopping Treatment”